Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)Product type:GuidanceProgramme:Highly specialised technologies guidanceLast updated: 8 April 2025Published: 10 October 2018
Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 7 April 2025Published: 23 June 2015
Epilepsies in children, young people and adults (NG217)Product type:GuidanceProgramme:NICE guidelineLast updated: 30 January 2025Published: 27 April 2022